Washington, Nov 10 (VOICE) The US Food and Drug Administration (FDA) has approved the world’s first chikungunya vaccine.The vaccine Ixchiq, developed by French biotech company Valneva, is approved for individuals 18 years of age and older, who are at increasedrisk of exposure to chikungunya virus. Ixchiq is administered as a…Read More
USFDA okays worlds first chikungunya vaccine Weekly Voice
